Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,604,638
+$466,197 QoQ
Shares Held
118,511
-37.6% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#121
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $2,466,204,715 across 17 Drug Manufacturers - General names. OGN ranks #16 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
689,850 | $827,426,853 | |
| 2 | JNJ |
Johnson & Johnson
|
1,608,573 | $408,529,284 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,713,402 | $220,172,157 | |
| 4 | ABBV |
AbbVie Inc.
|
728,959 | $183,435,241 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,034,568 | $130,707,319 | |
| 6 | AMGN |
Amgen Inc
|
343,610 | $124,428,052 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,153,285 | $124,072,280 | |
| 8 | AZN |
Astrazeneca PLC
|
572,746 | $108,604,096 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,604,638 | 118,511 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,138,441 | 190,057 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $748,547 | 104,400 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,030,590 | 658,295 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,282,202 | 648,988 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,836,555 | 660,615 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $9,610,507 | 644,136 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $13,147,875 | 687,291 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $12,174,041 | 588,118 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $10,733,144 | 570,912 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $6,280,471 | 435,539 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $7,837,466 | 451,467 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,344,291 | 449,029 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,779,074 | 415,777 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $8,548,171 | 306,057 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $7,026,223 | 300,266 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,879,774 | 381,623 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $13,245,209 | 379,193 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $10,924,271 | 358,761 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,801,947 | 298,931 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $3,741,860 | 123,657 | Shares | Defined | 2021-08-06 | |
| No filing history on record for this holder in this stock. | ||||||